Skip to main content
Caplight Logo









IpiNovyx Bio

IpiNovyx Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.ipinovyx.com/

Last Round

Seed

Oct 5, 2021

Total Funding Raised

$10M

Company Overview

IpiNovyx Bio is a biotechnology company developing a platform of selective and reversible immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immunoproteasome inhibitorssmall-molecule drugsdrug discoverybiotechoncologyautoimmune diseasepreclinical developmenttherapeutic pipelinedrug developmentinflammatory diseasebiopharmadrug candidatemedicinal chemistryproteasome modulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IpiNovyx Bio Comparables

Compare IpiNovyx Bio with similar companies based on industry and business-model similarity.

IpiNovyx Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iProtics
88%
QLi5 Therapeutics GmbH
82%
Enodia Therapeutics
71%

IpiNovyx Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 5, 2021

IpiNovyx Bio Investors

Notable investors and investment history

IpiNovyx Bio investors
InvestorRounds
Viva BioInnovatorSeed
Alexandria Venture InvestmentsSeed

IpiNovyx Bio Filings

Explore SEC and related filing metadata, where available.

IpiNovyx Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about IpiNovyx Bio's valuation, stock price, and market status.

Is IpiNovyx Bio a public or private company?

IpiNovyx Bio is a private company.

What is the current stock price of IpiNovyx Bio?

IpiNovyx Bio is a private company with no public stock price. No recent secondary market data is available.

How much is IpiNovyx Bio worth (valuation)?

Valuation information for IpiNovyx Bio is not publicly available.

Can I buy IpiNovyx Bio stock?

IpiNovyx Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was IpiNovyx Bio's last funding round?

IpiNovyx Bio's most recent funding round was Seed on October 5, 2021.

Who are the main investors in IpiNovyx Bio?

Key investors in IpiNovyx Bio include Viva BioInnovator.

Will IpiNovyx Bio IPO soon?

No public IPO plans have been announced for IpiNovyx Bio.

How can I track IpiNovyx Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IpiNovyx Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2021
Last FundingOct 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?